U.S. Healthtech Stock News

Carrier Global (CARR) is back in focus after reporting very large growth in data center related orders, a 35% jump in global Commercial HVAC orders, and reaffirming full year 2026 sales guidance of about US$22b. See our latest analysis for Carrier Global. Despite a modest 1-day share price move and a 7-day share price return that is down 3.43%, Carrier Global’s year-to-date share price return of 22.51% and 3-year total shareholder return of 59.25% point to momentum that remains largely...

Rezolve AI (RZLV) is back in focus after announcing a global partnership with Tata Consultancy Services, under which TCS will resell Rezolve’s AI commerce platform to enterprise clients worldwide and showcase the technology in its Pace Port centers. See our latest analysis for Rezolve AI. The TCS deal lands after an active few weeks, including Rezolve AI’s April guidance reiteration for 2026 revenue of $360 million and the Revolut listing of its SQD token. Yet the stock still sits at a share...

Moderna (NasdaqGS:MRNA) ranked no. 1 on TIME's 2026 World's Most Impactful Companies list. The company received European approval for mCOMBRIAX, its first combined flu and COVID vaccine. These developments expand Moderna's recognized societal role and add a new approved product beyond COVID-only vaccines. For investors following Moderna, this recognition and new approval come as the company continues to build around its mRNA platform in vaccines and therapeutics. The flu plus COVID product...

Wondering whether Howard Hughes Holdings at around US$64.21 is priced for a rebound or still has more to prove on value? This article focuses squarely on what the current share price might imply. The stock has been fairly flat in the short term, up about 0.1% over the last week and down 0.2% over the last month, while the share price has declined 18.5% year to date and 9.6% over the last year. Those longer term moves sit against a backdrop of ongoing interest in real estate development and...

Astronics (ATRO) opened 2026 with Q1 revenue of US$230.6 million and basic EPS of US$1.38, setting a clear marker for how the year is starting after a busy 2025. The company has seen quarterly revenue move from US$205.9 million and EPS of US$0.27 in Q1 2025 to US$230.6 million and EPS of US$1.38 in Q1 2026, while trailing twelve month revenue sits at US$886.8 million and EPS at US$1.28. This puts the spotlight firmly on how much of this uplift is sticking in margins. See our full analysis for...

Broadwind (BWEN) opened Q1 2026 with revenue of US$34.1 million and a basic EPS loss of US$0.02, compared with revenue of US$36.8 million and a basic EPS loss of US$0.02 in Q1 2025, while trailing twelve month EPS stood at US$0.22 on revenue of US$155.3 million. Over recent quarters the company has seen revenue move from US$33.6 million in Q4 2024 to US$36.8 million in Q1 2025, then to US$39.2 million in Q2 2025, US$44.2 million in Q3 2025, US$37.7 million in Q4 2025, and US$34.1 million in...

Recent performance snapshot for Star Bulk Carriers (SBLK) Without a specific news catalyst, Star Bulk Carriers (SBLK) has drawn attention after a mixed short term performance, with the stock down over the past day and week but higher over the month and past 3 months. Over the past day the stock declined about 2.4%, while the past week is slightly lower. In contrast, the share price is higher over the month, past 3 months, year to date, and the past year. These moves come alongside reported...

In early May 2026, Starbucks launched cash tender offers of up to US$1.10 billion to repurchase multiple series of outstanding senior notes, while also reporting that fiscal Q2 2026 brought renewed growth in revenue and earnings and raising its full-year outlook. Alongside this financial repositioning, Starbucks is pushing operational and geographic changes, from sustainability-focused store expansion in southern Chile to a new Nashville corporate office and selective tech layoffs, that...

Aflac (NYSE:AFL) is spotlighting its Check for Cancer Champion initiative, honoring television personality Adamari López for her cancer awareness advocacy. Separately, a regulatory filing disclosed that J&A Alliance Holdings, linked to Japan Post Holdings, holds a 10% stake in Aflac. Aflac, trading at $115.48, has a track record that includes a 13.6% return over the past year and 130.9% over the past 5 years. Those figures, alongside a 4.8% return year to date, suggest that many investors...

If you are wondering whether Autodesk at around US$231 per share is offering fair value or a potential mispricing, the current setup in the stock makes that question especially relevant. The share price is down about 5% over the last week and about 19.4% year to date, while the 1 year return is a decline of 21.8% and the 3 year return is a gain of 16.4%. Together, these figures suggest shifting expectations and changing risk appetite around the stock. Recent coverage has focused on Autodesk...

Morgan Stanley (MS) is back in focus after reporting a record Q1 2026, with CEO Ted Pick pointing to strong Investment Banking, Markets and wealth management results alongside upbeat earnings estimate revisions. See our latest analysis for Morgan Stanley. The Q1 2026 update and recent product moves, including the launch of cryptocurrency trading on E*TRADE and new market access such as ADX remote membership, have come alongside a 30 day share price return of 7.01% and a 1 year total...

Earlier in 2026, Halliburton reported first-quarter adjusted earnings of US$0.55 per share, ahead of analyst expectations, after implementing cost reduction initiatives and limiting capital expenditure to US$192 million while holding about US$2.00 billion in cash and a debt-to-capitalization ratio of 39.6%. In a separate move, Halliburton joined Blackstone in a US$1.00 billion equity investment in VoltaGrid, underscoring its interest in behind-the-meter power solutions that support data...

PagSeguro Digital (NYSE:PAGS) has just opened its Q1 2026 earnings season with revenue of R$5.0b and basic EPS of R$1.95, setting a clear marker for how the year is starting. The company has seen quarterly revenue move from R$4.7b in Q1 2025 to R$5.0b in Q1 2026, while basic EPS shifted from R$1.73 to R$1.95 over the same period, giving investors a concrete read on both top line scale and per share profitability. With trailing twelve month EPS at R$7.65 and net income at R$2.1b, the focus now...

Eastern Machine Ltd (NasdaqGM:EML) opened 2026 with Q1 revenue of about US$59.7 million and basic EPS of US$0.11, setting a measured tone for the new financial year. Over recent quarters the company has seen revenue move from US$65.9 million and EPS of US$0.35 in Q1 2025 to US$57.5 million and EPS of US$0.20 in Q4 2025, before landing at the latest Q1 2026 figures. This progression gives a clear view of how the top line and EPS have tracked into the current release. Taken together with a...

Netlist (NLST) has opened 2026 with Q1 revenue of about US$104.9 million and basic EPS of roughly US$0.03, setting a clear marker for how the business is currently converting its top line into per share results. The company has seen quarterly revenue move from US$34.3 million in Q4 2024 to US$28.9 million in Q1 2025, then up through US$41.7 million, US$42.2 million and US$75.7 million in the remaining quarters of 2025 to reach US$104.9 million in Q1 2026. Basic EPS has shifted from a loss of...

In the past quarter, Opendoor Technologies Inc. reported Q1 2026 sales of US$720 million versus US$1,153 million a year earlier, with net loss widening to US$173 million and basic and diluted loss per share from continuing operations at US$0.18 compared with US$0.12 previously. While sales declined and losses increased, management highlighted its “Opendoor 2.0” push toward resale velocity, inventory health, cost discipline, and AI-driven underwriting, alongside new offerings such as Opendoor...

AtriCure, Inc. has reported first-quarter 2026 results, with revenue of US$141.25 million up from US$123.62 million a year earlier and net income of US$0.108 million versus a net loss of US$6.75 million, marking a return to profitability. Management’s outlook for double-digit revenue expansion supported by recent product launches, including cryoSPHERE MAX and cryoXT, and growing adoption of the EnCompass and AtriClip platforms highlights how new devices and clinical investments are...

Understanding the recent move in HA Sustainable Infrastructure Capital stock HA Sustainable Infrastructure Capital (HASI) has drawn fresh interest after changing its name from Hannon Armstrong Sustainable Infrastructure Capital in June 2024. This has prompted investors to reassess what drives the stock and its fundamentals. See our latest analysis for HA Sustainable Infrastructure Capital. HASI’s share price has pulled back 0.8% over the past day and 6.2% over the past week, following a 27.7%...

Nextpower (NXT) has wrapped up FY 2026 with fourth quarter revenue of US$880.5 million and basic EPS of US$1.01, against trailing twelve month totals of US$3.6 billion in revenue and EPS of US$3.96, alongside EPS growth of 15.1% over the year. Over the past six quarters, the company has seen quarterly revenue move between US$679.4 million and US$924.3 million while quarterly EPS has ranged from US$0.80 to US$1.06, giving you a clear line of sight on how the current print sits within its...

Estée Lauder Companies (EL) is back in focus after fiscal third quarter results exceeded analyst expectations. Earnings per share came in well above forecasts, and fragrance revenue grew at a double digit rate. See our latest analysis for Estée Lauder Companies. Despite the recent earnings beat and raised full year outlook, the stock has been under pressure. The share price is down 23.1% year to date and the 3 year total shareholder return has declined 56.0%, while the 1 year total...

In recent months, Intuitive Surgical has faced FDA Class I recalls on certain da Vinci stapler components and visible institutional selling, raising concerns about product safety, regulatory scrutiny, and the resilience of its surgical robotics franchise. These events contrast with the company’s ongoing growth in da Vinci system installations and procedure volumes, sharpening the tension between operational momentum and rising risk perceptions among large investors. We’ll now explore how...

QXO (QXO) opened Q1 2026 with total revenue of US$1.7 billion and a basic EPS loss of US$0.31, as net income excluding extra items came in at a loss of US$227.1 million. Over the last five reported quarters, the company has seen revenue move from US$13.5 million in Q1 2025 to US$2.2 billion in Q4 2025 and then to US$1.7 billion in Q1 2026, while quarterly EPS moved from a loss of US$0.03 to a loss of US$0.17 and then to a loss of US$0.31 over the same stretch. For investors, the key focus...

Duke Energy (DUK) is back in focus after a busy start to May, with Q1 2026 results beating Wall Street expectations, dividends reaffirmed, and fresh financing plans tied to a larger multi year grid investment program. See our latest analysis for Duke Energy. Despite a busy stretch of earnings, capital plan updates and dividend declarations, Duke Energy’s share price has eased in the short term, with the 1 month share price return down about 5%. The 1 year total shareholder return of roughly...

Oculis Holding (NasdaqGM:OCS) has hit several key clinical milestones, including FDA Special Protocol Assessment agreement for its PIONEER-1 Phase 3 trial of Privosegtor in optic neuritis and completion of critical DIAMOND Phase 3 visits for OCS-01. See our latest analysis for Oculis Holding. Oculis Holding’s recent FDA SPA agreement for PIONEER-1 and progress in its DIAMOND Phase 3 program have come alongside a 56.85% year to date share price return and an 81.54% 1 year total shareholder...